SCHEMBL16363815

SCHEMBL16363815

C#CCSc1nnnn1-c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.71
▸ MAPT P10636 4/20 0.65
▸ ALDH1A1 P00352 10/20 0.65
▸ LMNA P02545 3/20 0.63
▸ TSHR P16473 2/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.63
▸ HPGD P15428 1/20 0.63
▸ MEN1 O00255 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ TDP1 Q9NUW8 2/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ NFKB1 P19838 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ NFKB2 Q00653 1/20 0.56
▸ RELA Q04206 1/20 0.56
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ PKM P14618 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.51
▸ KDM1A O60341 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11126118 0.84 ALDH1A1 (0.65) POLBMAPTALDH1A1LMNATSHR
SCHEMBL5815122 0.84 ALDH1A1 (0.65) POLBMAPTALDH1A1LMNATSHR
SCHEMBL10970208 0.79 ALDH1A1 (0.71) POLBMAPTALDH1A1LMNATSHR
SCHEMBL10973042 0.79 ALDH1A1 (0.71) POLBMAPTALDH1A1LMNATSHR
SCHEMBL10448232 0.79 ALDH1A1 (1.00) POLBMAPTALDH1A1LMNATSHR
SCHEMBL16472210 0.79 ALDH1A1 (0.71) POLBMAPTALDH1A1LMNATSHR
SCHEMBL9137875 0.79 ALDH1A1 (0.71) POLBMAPTALDH1A1LMNATSHR
SCHEMBL18026651 0.78 ALDH1A1 (0.69) POLBMAPTALDH1A1LMNATSHR
SCHEMBL8186954 0.78 ALDH1A1 (1.00) POLBMAPTALDH1A1LMNATSHR
SCHEMBL9180266 0.76 ALDH1A1 (0.61) POLBMAPTALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160244435-A1 EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS THE SCRIPPS RESEARCH INSTITUTE (US) 2016-08-25 — — US disclosed
US-20160244435-A1 EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS THE SCRIPPS RESEARCH INSTITUTE (US) 2016-08-25 — — US disclosed
WO-2014205414-A1 EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-12-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160244435-A1 EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS NQO1, TXN2, MPO POLB 1760/4885MAPT 2660/4885ALDH1A1 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback